Drug Shortage Report for PRISTIQ

Last updated on 2023-01-27 History
Report ID 177970
Drug Identification Number 02321106
Brand name PRISTIQ
Common or Proper name PRISTIQ
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) DESVENLAFAXINE
Strength(s) 100MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 30's
ATC code N06AX
ATC description ANTIDEPRESSANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2023-02-01
Actual start date
Estimated end date 2023-03-27
Actual end date
Shortage status Anticipated shortage
Updated date 2023-01-27
Company comments Limited inventory available and on preventative allocation.
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2023-01-27 French Compare
v6 2023-01-27 English Compare
v5 2023-01-23 English Compare
v4 2023-01-09 French Compare
v3 2023-01-09 English Compare
v2 2022-12-12 French Compare
v1 2022-12-12 English Compare

Showing 1 to 7 of 7